BASEL: According to the world’s biggest maker of cancer drugs, Roche Holding AG
Mum
Ranbaxy Laboratories has got sanction from the US Food and Drug Administration (USFDA) to produce and market Hydrocodone Bitartrate and Acetaminophen Tablets USP, 75 mg/750 mg, 10 mg/500 mg, 5 mg/500 mg, and 10 mg/325 mg strengths.
.
Esteemed India:: India Media Hub:: Indian Rummy:: Latest News:: Mid-Cap Stocks:: Sports Bazaar
BASEL: According to the world’s biggest maker of cancer drugs, Roche Holding AG
Mum
Ranbaxy Laboratories has got sanction from the US Food and Drug Administration (USFDA) to produce and market Hydrocodone Bitartrate and Acetaminophen Tablets USP, 75 mg/750 mg, 10 mg/500 mg, 5 mg/500 mg, and 10 mg/325 mg strengths. 
